Helio Health
Helio Genomics Sister Firm LAMH Receives NMPA Approval in China for Blood-Based Liver Cancer Test
The liquid biopsy assay is a modified version of Helio's HelioLiver test that is tailored to the unique genetic makeup of the Asia-Pacific population.
In Brief This Week: OpGen, Thermo Fisher Scientific, Neogen, More
News items for the week of July 4, 2022.
In Brief This Week: Strata Oncology, University of Maryland Medicine, Helio Health, More
News items for the week of June 20, 2022.
Fujifilm, Helio Health Collaborate on Blood-Based Liver Cancer Test
Under the agreement, Helio Health's DNA methylation and biomarker-based blood test technology will be used with Fujifilm's μTASWako i30 immunoanalyzer.
Helio Health, China's National Cancer Center Partner to Develop Blood-Based Liver Cancer Diagnostic
Irvine, California-based Helio Health will launch a prospective study in China evaluating the performance of the Helio Liver Test in 3,000 subjects.